BioRestorative Therapies, Inc. (BRTX) Q1 2025 Earnings Call Transcript
…
1,480$
2,78%
Echtzeit-Aktienkurs BioRestorative Therapies Inc.
Bid:
Ask:
Nachrichten zur BioRestorative Therapies Inc. Aktie
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Lags Revenue Estimates
Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of -75% and 91.67%, respectively, for the quarter ended March 2025. Do…
BioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call Transcript
…
BioRestorative Therapies, Inc. (BRTX) Q2 2024 Earnings Call Transcript
…
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates
Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of 10.71% and 196.67%, respectively, for the quarter ended June 2024. Do…
BioRestorative Therapies reports Q1 results
…
BioRestorative Therapies, Inc. (BRTX) Q1 2024 Earnings Call Transcript
…
Degenerative Disc Disease Drug Pipeline Research Report 2024 Featuring Spine BioPharma, Angitia Biopharmaceuticals, Mesoblast, BioRestorative Therapies, and DiscGenics, Inc.
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Degenerative Disc Disease - Pipeline Insight, 2024" clinical trials has…